A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR)
Clinical trial NCT04576988 · COMPLETED
Trial details
- NCT number
- NCT04576988
- Sponsor
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-25
- Primary completion
- 2022-08-26
- Enrollment
- 324
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.